Profound Medical Corp. Logo

Profound Medical Corp. (PRN)

TSX

Currency in CAD
10.14
+0.50 (+5.19%)

Closed

Nov 6, 2026

Day's Range

8.60
10.19

52 wk Range

6.52
12.40

Overview - PRN - Profound Medical Corp.

Key Statistics

Valuation

Enterprise Value

355.25M

P/E (Trailing)

‪-5.56‬

P/E (Forward)

‪-9.40‬

PEG Ratio

‪0.11‬

Price / Sales (TTM)

‪14.91‬

Price / Book

‪4.06‬

EV / EBITDA

‪-7.27‬

Profitability

Gross Margin

‪78.41%‬

Profit Margin

‪-171.56%‬

Operating Margin

‪-445.67%‬

Return on Assets

‪-39.45%‬

Return on Equity

‪-73.52%‬

Ownership

Shares Outstanding

36.53M

Float

35.50M

Short % of Shares Outstanding

‪0.97%‬

Held by Insiders

‪4.08%‬

Held by Institutions

‪45.14%‬

Price stats

Beta

‪0.55‬

50-Day Avg

‪8.84‬

200-Day Avg

‪9.35‬

Analyst Consensus

Buy

5 analysts

Latest News - PRN - Profound Medical Corp.

News & Analysis

View all news

Market Cap - PRN - Profound Medical Corp.

Peers - PRN - Profound Medical Corp.

Peer Comparison

Compared with companies in Medical Devices listed on TSX.

Profile Summary - PRN - Profound Medical Corp.

About

Profound Medical Corp. is a commercial-stage medical device company focused on developing and marketing incision-free therapeutic systems for image-guided ablation of diseased tissue. Its flagship TULSA-PRO system combines real-time MRI, AI-assisted planning, robotically driven transurethral ultrasound, and…

SectorHealthcare
IndustryMedical Devices
Employees162
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.